- Home
- / Chipscreen Biosciences
Chipscreen Biosciences
Stock Price
¥23.2
2024-10-29
Market Capitalization
¥9.2 B
2024-10-29
Revenue
¥636.1 M
FY, 2024
Chipscreen Biosciences Summary
Company Summary
- Overview
- Shenzhen Chipscreen Biosciences (微芯生物) is biotech company engaged in research and development of small-molecule drugs. It uses a proprietary integrated drug discovery and early evaluation platform based on chemical genetics to provide pharmaceuticals for the treatment of tumors, diabetes, as well as endocrine and autoimmune diseases.
- Type
- Public
- Status
- Active
- Founded
- 2001
- Website
- https://www.chipscreen.com
- Cybersecurity rating
- ESG rating
Table of Contents
Chipscreen Biosciences Financials
Summary Financials
- Revenue (Q1, 2025)
- ¥160.3M
- Gross profit (Q1, 2025)
- ¥137.0M
- Net income (Q1, 2025)
- (¥19.2M)
- Cash (Q1, 2025)
- ¥369.3M
- EBIT (Q1, 2025)
- (¥8.2M)
- Enterprise value
- $10.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025